In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GSK, Jiangsu create pediatric vaccines JV for Chinese market; terminated

Executive Summary

GlaxoSmithKline and Jiangsu Walvax Biotech (viral vaccines) have agreed to invest a total of £41.2mm ($66mm) in a long-term joint venture focused on pediatric vaccines for the Chinese market.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Equity
    • Joint Venture
    • Marketing (Licensing)

Related Companies